Torsades de Pointes Akibat Bradikardia

Authors

  • James C. Kurniawan Universitas Sam Ratulangi
  • Benny M. Setiadi Universitas Sam Ratulangi
  • Starry H. Rampengan Universitas Sam Ratulangi

DOI:

https://doi.org/10.35790/msj.v7i1.54391

Abstract

Abstract: Torsades de pointes (TdP) is a fatal tachyarrhythmia that has the potential to degenerate into ventricular fibrillation. The occurrence of TdP is associated with prolongation of the QT interval on the electrocardiogram (ECG), which is often found in bradycardia patients. We reported an 86-year-old female who experienced recurrent fainting episodes in the past month. From the ECG we recorded sinus rhythm was bradycardia with a heart rate of 43 bpm with a high degree of atrioventricular block, with a prolongation of the QT interval reaching 640 milliseconds. The patient was not taking any medications known to have the effect of prolonging the QT interval. The patient underwent a series of examination. Blood and electrolyte tests were within normal limit. Echocardiography examination showed good heart pump function and no structural abnormalities were found. The 24-hour Holter examination recorded a TdP rhythm with a heart rate of 180 bpm which was spontaneos termination. The patient underwent a permanent dual chamber pacemaker implantation. At post-insertion follow-up, the patient never experienced another fainting episode. In conclusion, bradycardia on ECG is known to prolong the QT interval thereby predisposing to torsades de pointes. Implantation of a permanent pacemaker was done and was successful in treating bradycardia, shortening the QT interval thereby suppressing the occurrence of torsades de pointes.

Keywords: torsades de pointes; bradycardia; atrioventricular block

  

Abstrak: Torsades de pointes (TdP) merupakan takiaritmia fatal yang berpotensi berdegenerasi menjadi fibrilasi ventrikel. Kejadian TdP dikaitkan dengan pemanjangan interval QT pada elektrokardiogram (EKG), yang seringkali dijumpai pada pasien bradikardia. Kami melaporkan kasus seorang pasien wanita berusia 86 tahun yang mengalami episode pingsan berulang dalam satu bulan terakhir. Dari gambaran  EKG didapatkan irama sinus bradikardia dengan laju jantung 43x per menit dengan blok atrioventrikular derajat tinggi, dengan pemanjangan interval QT mencapai 640 milidetik. Pasien tidak mengonsumsi obat-obatan yang diketahui memiliki efek memperpanjang interval QT. Pasien menjalani serangkaian penunjang. Pemeriksaan darah dan elektrolit hasilnya normal. Pemeriksaan ekokardiografi menunjukkan fungsi pompa jantung baik dan tidak ditemukan adanya abnormalitas struktur jantung. Pemeriksaan Holter 24 jam berhasil merekam irama TdP dengan laju jantung 180x per menit yang mengalami terminasi spontan. Pada pasien dilakukan pemasangan alat pacu jantung permanen dual chamber. Pada follow up paska pemasangan, pasien tidak pernah mengalami episode pingsan lagi. Simpulan kasus ini ialah bradikardia pada elektrokardiogram diketahui memperpanjang interval QT sehingga memredisposisi terjadinya TdP. Pemasangan alat pacu jantung permanen pada pasien dipilih sebagai langkah tatalaksana, dan terbukti berhasil mengatasi bradikardia, memperpendek interval QT sehingga mensupresi terjadinya torsades de pointes.

Kata kunci: torsades de pointes; bradikardia; blok atrioventrikular

Author Biographies

James C. Kurniawan, Universitas Sam Ratulangi

Program Pendidikan Dokter Spesialis-I Bagian Kardiologi dan Kedokteran Vaskular, Universitas Sam Ratulangi, Manado, Indonesia

Benny M. Setiadi, Universitas Sam Ratulangi

Bagian Kardiologi dan Kedokteran Vaskular, Universitas Sam Ratulangi, Manado Indonesia

Starry H. Rampengan, Universitas Sam Ratulangi

Bagian Kardiologi dan Kedokteran Vaskular, Universitas Sam Ratulangi, Manado Indonesia

References

Dessertenne F. La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur. 1966;59:263-72. Available from: pubmed.ncbi.nlm.nih.gov/4956181/

Sarganas G, Garbe E, Klimpel A, Hering RC, Bronder E, Haverkamp W. Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany. Europace. 2014;16(1):101-8. Doi: 10.1093/europace/eut214

Vandael E, Vandenberk B, Vandenberghe J, Pincé H, Willems R, Foulon V. Incidence of torsade de pointes in a tertiary hospital population. Int J Cardiol. 2017;243:511-5. Doi: 10.1016/j.ijcard.2017.05.072

Novotný T. Mechanisms and incidence of torsades de pointes tachycardia. Sex and Cardiac Electrophysiolog (Chapter 6). Elsevier; 2020. p. 303-8. Doi:10.1016/B978-0-12-817728-0.00026-7

Shehadeh MSS, Pollevick M, Rubin GA, Wan EY, Saluja D, Dizon JM, et al. Hirad Yarmohammadi. Incidence, Trends and In-Hospital Course and Outcomes of Torsades de Pointes. Cardiology and Cardiovascular Medicine. 2024;8:25-32. Doi:10.26502/fccm.92920354

Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121(8):1047-60. Doi: https://doi.org/ 10.1016/j.jacc.2010.01.001

Smirk FH. R waves interrupting T waves. British Heart Journal. 1949;11(1):23. Doi: https://doi.org/ 10.1136/hrt.11.1.23

Kallergis EM, Goudis CA, Simantirakis EN, Kochiadakis GE, Vardas PE. Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. The Scientific World Journal (TSWJ). 2012;2012:212178. Doi: https://doi.org/10.1100/2012/212178

Coppola C, Rienzo A, Piscopo G, Barbieri A, Arra C, Maurea N. Management of QT prolongation induced by anti-cancer drugs: target therapy and old agents. Different algorithms for different drugs. Cancer Treat Rev. 2018;63:135-43. Doi: https://doi.org/10.1016/j.ctrv.2017.11.009

Aktürk G, Kalkan Ş. Drug-induced QT interval prolongation: mechanisms, risk factors, genetics and clinical management. J Basic Clin Health Sci. 2019;3(3):193-8. Doi: https://doi.org/10.30621/ jbachs.2019.712

Kahlon SS, Sikandar R, Tejovath S, Nair S, Hassan D, Patel KK, et al. Diagnosing torsades de pointes based on correlation to QT interval: a systematic review. Cureus. 2022;14(8):e278333. Doi: https://doi.org/10.7759%2Fcureus.27833

Khan IA, Gowda RM. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes. Int J Cardiol. 2004;95(1):1-6. Doi: https://doi.org/10.1016/j.ijcard.2003.04.018

Dorostkar PC, Eldar M, Belhassen B, Scheinman MM. Long-term follow-up of patients with long-QT syndrome treated with β-blockers and continuous pacing. Circulation. 1999;100(24):2431-6. Doi: https://doi.org/10.1161/01.cir.100.24.2431

Welde AAM. Is there a role for implantable cardioverter defibrillators in long QT syndrome? Journal of cardiovascular electrophysiology (JCE). 2002;13(S1):S110-S3.

Cho MS, Nam G-B, Kim Y-G, Hwang K-W, Kim YR, Choi H, et al. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block. Heart Rhythm. 2015;12(3):498-505. Doi: https://doi.org/10.1016/j.hrthm.2014.11.018

Downloads

Published

2024-06-05

How to Cite

Kurniawan, J. C., Setiadi, B. M., & Rampengan, S. H. (2024). Torsades de Pointes Akibat Bradikardia . Medical Scope Journal, 7(1), 56–63. https://doi.org/10.35790/msj.v7i1.54391